EE200200497A - Oral Controlled-Release Systems for Ciprofloxacin Daily Administration - Google Patents

Oral Controlled-Release Systems for Ciprofloxacin Daily Administration

Info

Publication number
EE200200497A
EE200200497A EEP200200497A EEP200200497A EE200200497A EE 200200497 A EE200200497 A EE 200200497A EE P200200497 A EEP200200497 A EE P200200497A EE P200200497 A EEP200200497 A EE P200200497A EE 200200497 A EE200200497 A EE 200200497A
Authority
EE
Estonia
Prior art keywords
ciprofloxacin
daily administration
release systems
oral controlled
oral
Prior art date
Application number
EEP200200497A
Other languages
Estonian (et)
Inventor
Talwar Naresh
N. Staniforth John
Rampal Ashok
Mukherji Gour
N. Vishwanathan Badri
Khera Brij
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of EE200200497A publication Critical patent/EE200200497A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200200497A 2000-03-03 2001-02-28 Oral Controlled-Release Systems for Ciprofloxacin Daily Administration EE200200497A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03
PCT/IB2001/000279 WO2001064183A1 (en) 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily administration of ciprofloxacin

Publications (1)

Publication Number Publication Date
EE200200497A true EE200200497A (en) 2004-02-16

Family

ID=24061635

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200497A EE200200497A (en) 2000-03-03 2001-02-28 Oral Controlled-Release Systems for Ciprofloxacin Daily Administration

Country Status (31)

Country Link
EP (1) EP1263409A1 (en)
JP (1) JP2003525229A (en)
KR (1) KR20030009374A (en)
CN (1) CN1420763A (en)
AP (2) AP2001002084A0 (en)
AR (1) AR032614A1 (en)
AU (1) AU3589701A (en)
BG (1) BG107055A (en)
BR (1) BR0108958A (en)
CA (1) CA2400950A1 (en)
CZ (1) CZ20022883A3 (en)
DO (1) DOP2001000130A (en)
EA (1) EA200200914A1 (en)
EC (1) ECSP013952A (en)
EE (1) EE200200497A (en)
GT (1) GT200100033A (en)
HN (1) HN2001000038A (en)
HR (1) HRP20020715A2 (en)
HU (1) HUP0204417A3 (en)
IL (1) IL151553A0 (en)
IS (1) IS6532A (en)
MX (1) MXPA02008568A (en)
NO (1) NO20024108L (en)
NZ (1) NZ520927A (en)
OA (1) OA12381A (en)
PE (1) PE20011113A1 (en)
PL (1) PL365071A1 (en)
SK (1) SK12542002A3 (en)
WO (1) WO2001064183A1 (en)
YU (1) YU66202A (en)
ZA (1) ZA200206764B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (en) 2003-11-04 2005-06-09 Bayer Healthcare Ag Flavor-containing drug formulations with improved pharmaceutical properties
EP1745775B1 (en) * 2005-07-19 2008-05-28 Ethypharm Gastroretentive formulations and manufacturing process thereof.
EP1880722B1 (en) * 2006-07-19 2010-03-17 Tabuk Pharmaceutical Manufacturing Co. Pharmaceutical compositions of ciprofloxacin
WO2016115253A1 (en) 2015-01-14 2016-07-21 The Regents Of The University Ofcolordo, A Body Corporate Insulin mimotopes and methods of using the same
EP3419669A4 (en) * 2016-02-23 2019-10-30 Matripharm International Inc. Dual-rate release formulation with high drug loading
AU2017236977B2 (en) 2016-03-24 2022-05-26 Immunomolecular Therapeutics, Inc. Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
CN109806237A (en) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 A kind of Ciprofloxacin Lactate effervescent tablet and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (en) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk Medice release solid pharmaceutical preparation of gastric suspending type sustained
DE4406424A1 (en) * 1994-02-28 1995-08-31 Bayer Ag Expandable dosage forms
DE19839057A1 (en) * 1998-08-28 2000-03-02 Koch Berthold Purge air controller for a drying device for compressed air
EA004443B1 (en) * 1998-09-14 2004-04-29 Рэнбакси Лабораториз Лимитед Pharmaceutical formulation for controlled release of ciprofloxacin for one administration per day

Also Published As

Publication number Publication date
OA12381A (en) 2004-09-06
CZ20022883A3 (en) 2003-04-16
KR20030009374A (en) 2003-01-29
WO2001064183A1 (en) 2001-09-07
IS6532A (en) 2002-08-28
EP1263409A1 (en) 2002-12-11
CN1420763A (en) 2003-05-28
HN2001000038A (en) 2005-03-23
NO20024108D0 (en) 2002-08-28
AU3589701A (en) 2001-09-12
BG107055A (en) 2003-06-30
MXPA02008568A (en) 2003-02-24
HRP20020715A2 (en) 2004-12-31
AP2002002627A0 (en) 2002-09-30
IL151553A0 (en) 2003-04-10
PL365071A1 (en) 2004-12-27
AP1485A (en) 2005-10-31
NO20024108L (en) 2002-10-25
GT200100033A (en) 2001-10-25
HUP0204417A2 (en) 2003-05-28
AR032614A1 (en) 2003-11-19
CA2400950A1 (en) 2001-09-07
PE20011113A1 (en) 2001-10-14
YU66202A (en) 2005-09-19
EA200200914A1 (en) 2003-02-27
ZA200206764B (en) 2003-03-04
BR0108958A (en) 2003-09-30
HUP0204417A3 (en) 2005-03-29
NZ520927A (en) 2003-06-30
DOP2001000130A (en) 2004-03-31
SK12542002A3 (en) 2003-05-02
JP2003525229A (en) 2003-08-26
AP2001002084A0 (en) 2001-03-31
ECSP013952A (en) 2002-04-23

Similar Documents

Publication Publication Date Title
NO20020976L (en) Retarded, oral, pharmaceutical forms of administration
DE60138706D1 (en) MISS-IN-HOUSE ORAL OPIOID AGONIST PREPARATIONS
EE05581B1 (en) Aripiprazole oral solution for oral administration
NO20014035D0 (en) Oral drug administration system
DE122008000001I1 (en) Oral prolonged release dosage compositions
NO20030627L (en) Hydrogel-driven drug dosage form
NO20022970L (en) Hydrogel-driven drug dosage form
DK1335678T3 (en) Oral treatment system
EE200000497A (en) Fast dissolving oral dosage form
ATE306253T1 (en) ORAL BIOADHESIVE TABLET WITH EXTENDED RELEASE
DE50212546D1 (en) ORAL PHARMACEUTICAL FORMS FOR PROPIMERIN OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS WITH EXTENDED ACTIVE INGREDIENT EXTRACTION
DK1043976T3 (en) Oral pharmaceutical dosage form with sustained release
NO20003968L (en) Pharmaceutical preparations
TR200003787A3 (en) Stable slow-release oral dosage composition.
DE60126089D1 (en) ADMINISTRATION SYSTEM
EE05375B1 (en) Levosimendan Pharmaceutical Formulations
NO20014738L (en) Tolperisone-containing pharmaceutical preparation for oral administration
EE200200497A (en) Oral Controlled-Release Systems for Ciprofloxacin Daily Administration
AU2001284444A1 (en) Preparations for oral administration
ATE348599T1 (en) DRONEDARON PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION
FI20000780A (en) Oral dosage form for controlled release of the drug
DK1216032T3 (en) Controlled-release oral formulations
NO20040857L (en) New oral prolonged release dosage form.
AU2001248943A1 (en) Pharmaceutical curative compound
ITMI991742A0 (en) BISPLATIN COMPLEXES ACTIVE ORALLY